We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+15.23%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+679.66%
AUM
$9.06B
AUM Growth
+$842M
Cap. Flow
-$183M
Cap. Flow %
-2.02%
Top 10 Hldgs %
24.16%
Holding
331
New
23
Increased
115
Reduced
72
Closed
23

Top Buys

Rank Stock Value
1
MMSI icon
Merit Medical Systems
MMSI
+$43.7M
2
ALGN icon
Align Technology
ALGN
+$36.6M
3
STE icon
Steris
STE
+$32.7M
4
DOCS icon
Doximity
DOCS
+$32.4M
5
TRMB icon
Trimble
TRMB
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 26.48%
2 Technology 23.61%
3 Industrials 15.35%
4 Consumer Discretionary 14.47%
5 Communication Services 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNA
151
DELISTED
Paragon 28, Inc.
FNA
$9.37M 0.1%
753,648
-277,553
-27% -$2.94M
ACTG icon
152
Acacia Research
ACTG
$470M
$9.25M 0.1%
2,359,662
CCK icon
153
Crown Holdings
CCK
$13.1B
$9.21M 0.1%
100,000
-31,605
-24% -$2.68M
APTV icon
154
Aptiv
APTV
$10.3B
$9.15M 0.1%
102,000
-15,000
-13% -$1.29M
RIVN icon
155
Rivian
RIVN
$23.2B
$9.15M 0.1%
389,823
+150,653
+63% +$2.83M
APA icon
156
APA Corp
APA
$13.2B
$8.97M 0.1%
250,125
-33,875
-12% -$1.28M
AVY icon
157
Avery Dennison
AVY
$13.4B
$8.92M 0.1%
44,138
+5,454
+14% +$1.02M
CPAY icon
158
Corpay
CPAY
$25.7B
$8.49M 0.09%
30,047
+3,052
+11% +$758K
PMVP icon
159
PMV Pharmaceuticals
PMVP
$63.5M
$8.41M 0.09%
2,714,143
+2,443,717
+904% +$6.47M
RELY icon
160
Remitly
RELY
$5.14B
$8.4M 0.09%
+432,779
New +$9.7M
BIP icon
161
Brookfield Infrastructure Partners
BIP
$18B
$8.39M 0.09%
266,325
+8,900
+3% +$241K
AMPL icon
162
Amplitude
AMPL
$1.41B
$8.38M 0.09%
658,908
+177,533
+37% +$1.97M
HNST icon
163
The Honest Company
HNST
$586M
$8.32M 0.09%
2,522,421
-738,716
-23% -$1.35M
RPC
164
Ridgepost Capital
RPC
$991M
$8.26M 0.09%
808,494
-7,158
-0.9% -$70.7K
BRO icon
165
Brown & Brown
BRO
$23.9B
$8.14M 0.09%
114,479
+11,204
+11% +$801K
BANX
166
ArrowMark Financial
BANX
$199M
$8.07M 0.09%
445,576
-35,033
-7% -$608K
ROG icon
167
Rogers Corp
ROG
$2.4B
$7.92M 0.09%
60,000
PCYO icon
168
Pure Cycle
PCYO
$261M
$7.91M 0.09%
755,647
+9,610
+1% +$95.5K
BN icon
169
Brookfield
BN
$108B
$7.68M 0.08%
287,028
DORM icon
170
Dorman Products
DORM
$4.18B
$7.57M 0.08%
+90,738
New +$6.78M
ZM icon
171
Zoom
ZM
$30.6B
$7.55M 0.08%
105,000
CLAR icon
172
Clarus
CLAR
$143M
$7.54M 0.08%
1,094,119
+224,582
+26% +$1.32M
BELFB
173
Bel Fuse Inc Class B
BELFB
$4.21B
$7.44M 0.08%
111,478
-27,353
-20% -$1.46M
RYZB
174
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$7.29M 0.08%
117,306
+6,195
+6% +$154K
OLN icon
175
Olin
OLN
$2.12B
$7.28M 0.08%
135,000

Similar funds

ArrowMark Colorado Holdings's Q4 2023 Portfolio in Review

As of Q4 2023, ArrowMark Colorado Holdings held 331 positions worth $9.06B, up 10% from $8.22B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

ArrowMark Colorado Holdings's Q4 2023 filing shows 23 new, 115 increased, 72 reduced and 23 closed positions. Its largest new stake was Elastic: 310,882 shares worth $35M. The largest sale was Henry Schein, an estimated $93.7M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • ArrowMark Colorado Holdings's largest Q4 2023 buy was Elastic: 310,882 shares worth $35M.
  • ArrowMark Colorado Holdings added most to Merit Medical Systems in Q4 2023, an estimated $43.7M increase.
  • ArrowMark Colorado Holdings's biggest Q4 2023 reduction was Henry Schein, cutting an estimated $93.7M.
  • ArrowMark Colorado Holdings fully exited Tennant Co in Q4 2023, selling an estimated $73.2M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 24% of its $9.06B portfolio in Q4 2023.
  • ArrowMark Colorado Holdings opened 23 new positions and closed 23 in Q4 2023.
  • ArrowMark Colorado Holdings's portfolio value rose 10% quarter-over-quarter to $9.06B.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.